Martin Zweifel
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 3
- Hepatology top 10%
- Toxicology top 10%
-
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- Organic Chemistry top 10%
-
- MRI in cancer diagnosis 4
- Medical Imaging Techniques and Applications 2
-
- Angiogenesis and VEGF in Cancer 4
-
- Ovarian cancer diagnosis and treatment 4
-
- Mast cells and histamine 4
- Co-authors
- Anwar R. PadhaniGordon RustinJai BalkissoonDavid J. ChaplinPaul NathanFrank StennerPanagiotis SamarasBassam Abdul Rasool Hassan
- Cited by
- Cancer ResearchHepatologyToxicology
- Journals
- Annals of Oncology (3 papers)British Journal of Cancer (2 papers)Anticancer Research (2 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Martin Zweifel
35 papers receiving 975 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 168
- Hepatology 83
- Toxicology 32
- Oncology 229
- Organic Chemistry 196
Countries citing papers authored by Martin Zweifel
This map shows the geographic impact of Martin Zweifel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Zweifel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Zweifel more than expected).
Fields of papers citing papers by Martin Zweifel
This network shows the impact of papers produced by Martin Zweifel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Zweifel. The network helps show where Martin Zweifel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin Zweifel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2020 | 4 | |
| 3 | 2018 | 4 | |
| 4 | 2017 | 18 | |
| 5 | 2016 | 2 | |
| 6 | 2015 | 26 | |
| 7 | 2015 | 35 | |
| 8 | 2013 | 8 | |
| 9 | 2012 | 38 | |
| 10 | 2011 | 7 | |
| 11 | 2011 | 135 | |
| 12 | 2010 | 26 | |
| 13 | 2010 | 116 | |
| 14 | 2010 | 57 | |
| 15 | 2010 | 16 | |
| 16 | 2009 | 10 | |
| 17 | 2008 | 18 | |
| 18 | 2006 | 23 | |
| 19 | 2002 | 30 | |
| 20 | Holdinggesellschaft und Konzern | 1973 | 0 |
About Martin Zweifel
Martin Zweifel is a scholar working on Immunology and Allergy, Reproductive Medicine, Oncology, Hepatology and Cancer Research, having authored 37 papers that have together received 987 indexed citations. Recurring topics across this work include MRI in cancer diagnosis (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Cancer Treatment and Pharmacology (4 papers), Ovarian cancer diagnosis and treatment (4 papers), Mast cells and histamine (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Medical Imaging Techniques and Applications (2 papers). The work is most often cited by research in Cancer Research (168 citations), Hepatology (83 citations), Toxicology (32 citations), Oncology (229 citations) and Organic Chemistry (196 citations). Martin Zweifel has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Anwar R. Padhani, Gordon Rustin, Jai Balkissoon, David J. Chaplin, Paul Nathan, Frank Stenner, Panagiotis Samaras, Bassam Abdul Rasool Hassan, Gordon C. Jayson and Lauren J. Bains. Their work appears in journals such as Annals of Oncology, British Journal of Cancer, Anticancer Research, BMC Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.